ADGRG6 and cancer: Patients with high ADGRG6 expression had a worse OS in multiple subgroups, including sex, cancer stages 1–2, T2–3 (tumor size >2 cm but ≤4 cm, >4 cm), N0 (no regional lymph node metastasis), and M0 (no distant metastasis) (Figure 3B–I).